Digital Pathology & AI in Drug Development & Clinical Trials: Applications & Challenges
- Utilising digital pathology improves the interface between drug discovery, translational research, and clinical trials, strengthening the partnership between pharmaceutical companies and contract research organisations
- AI applications and platforms are currently being used across all stages of drug discovery and development, from target identification to indication selection, stratification of patients to companion diagnostics, and post-marketing oversight
- Digitised pathology also offers tangible benefits for clinical trial efficiency by enhancing traditional workflows with tech enabled alternatives, enabling central and remote review and collaboration, improving logistics, and streamlining global trials